首页
登录
职称英语
Banking on SpermA)It came to him in a dream. Ole Schou
Banking on SpermA)It came to him in a dream. Ole Schou
游客
2024-02-06
17
管理
问题
Banking on Sperm
A)It came to him in a dream. Ole Schou was a young Danish business student when he awoke one morning two decades ago with images of spermatozoa swimming in his head. Schou’s strange nocturnal vision gave rise to an obsession. "Some people collect stamps; others play golf," he explains, "I studied sperm." With no scientific or medical training, Schou set out to make himself an expert,poring over the scientific literature and consulting specialists about different methods for freezing sperm. His goal: to establish "the best sperm bank in the world."
B)Schou’ s single-minded devotion has paid off. Cryos, the company he founded in 1987 in the Danish city, Aarhus, claims to be the world’s largest sperm bank, with more than 200 active donors and revenues nearing $1 million. In the high-tech world of modern reproduction, sperm is becoming a controversial business, and with his aggressive entrepreneurial flair, Schou is something of a trailblazer. Last year Cryos signed a special agreement with British authorities that will allow the firm to make bulk exports to a Scottish clinic that cannot find donors to meet its tough standards. Schou, 45, estimates that British sales could eventually bring the company more than $2 million annually.
C)Cryos has benefited from a bewildering patchwork of European rules governing sperm donation. In Britain, for example, the law dictates that a single donor can father only 10 children. In Denmark, whose population of 5 million is less than one-tenth of Britain’s, the limit is 25. In Austria and Sweden, laws allow children conceived through sperm donation to seek the identity of their parents when the children reach age 18. Denmark, however, has more sweeping protection of donor anonymity: Cryos does not maintain a record of its donor’ s names, using a coded identification number instead. According to Schou, the Swedish law has resulted in such a severe donor shortage that hundreds of Swedish couples seek help each year in Denmark. Attracting donors is not much of a problem in Aarhus, which has a large university population. But only about 10% of those who apply make it through the screening process, which includes a psychological assessment as well as a battery of medical tests to rule out HIV, hepatitis and other diseases.
D)Cryos does not maintain the exhaustive profiles of donor characteristics used by U.S. Sperm banks. The company limits its data to such fundamentals as hair and eye color, height and ethnic classification, which, says Schou, is the main difference from what he calls the "couture style" U.S. system of merchandising sperm. He is critical of the U.S. Reliance on "positive eugenics" his term for the penchant for selecting donors based on detailed genetic, physical and psychological profiles.
E)Schou believes sperm banks should practice "negative eugenics" testing for disease and severe genetic defects only to the extent that an average couple would. On the other hand, to supply a global marketplace, he is having to bend his principles. Cryos now supplies a few U.S. Clinics with sperm, and in those cases has begun to provide more extensive donor profiles. To serve increasing demand for non-Scandinavian ethnic types, Schou cooperates with a handful of overseas sperm banks.
F)Cryos appears likely to continue to dominate Europe’ s commercial sperm-donor industry, and its growing success is provoking some criticism. Charles Sims, a clinical pathologist who co-founded California Cryobank, the best-known U.S. Sperm bank, thinks Cryos’ claims of market dominance are misplaced. "Sperm is not a commodity," he says. "It’ s not something you’ re selling like aspirin. "But Ole Schou shrugs off those views. He is passionate about his company’s mission to help thousands of would-be parents. In fact, he and his wife are about to become first-time parents—the old-fashioned way. "We’ ve been working at it for many years, and believe me, it’ s not that easy". [br] It is estimated that the sperm exports to a Scottish clinic will bring an income of more than $2 million every year.
选项
答案
B
解析
题干:据估.计,出口到苏格兰一家诊所的精子每年会带来两百多万美元的收益。题干关键词是exports,Scottish clinic和$2 million。文中B段最后两句提到,去年.克瑞奥斯公司与英国当局签署了一项特殊的协议,这项协议允许该公司向一家苏格兰诊所批量出售精子,45岁的休乌预计英国的销售最终可以给公司每年带来200多万美元的收益。与题干意思吻合,故选B。
转载请注明原文地址:https://tihaiku.com/zcyy/3426065.html
相关试题推荐
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
BankingonSpermA)Itcametohiminadream.OleSchou
随机试题
Theissueofwhetherparentswhosechildrenareobeseshouldbechargedwith
Hegotuptotheroof______aladder.A、byallmeansB、byanymeansC、bymeanso
PeoplewerecertainThomas______hisfootontheroadtofamewhenhearrivedi
非ST段抬高性心肌梗死患者进行危险分层首选的心脏标志物是A.cTn B.Mb
二尖瓣面容的特点是()A.两颊部蝶形红斑 B.两颊部紫红,口唇轻度发绀
不属于抗惊厥药的是A.苯巴比妥B.水合氯醛C.地西泮D.硫酸镁E.卡马西平
公开发行股票的公司,其财务审计与资产评估工作可以由同一家机构承担。()
期货交易所因合并、分立或者解散而终止的,由()予以公告A.人民法院 B.
A.近效期药品 B.不合格药品 C.对由于异常原因可能出现问题的药品 D.
长期大量使用林旦后可导致下列哪种不良反应()A.肝脏损害 B.眼部水肿
最新回复
(
0
)